The Ritedose Corporation

The Ritedose Corporation company information, Employees & Contact Information

The Ritedose Corporation is a leader in blow-fill-seal(BFS) manufacturing of small fill volume pharmaceutical unit dose sterile and non-sterile liquids. We specialize in manufacturing inhalation products, eye drops, eardrops and unit dose oral liquids.

Company Details

Employees
322
Founded
-
Address
1 Technology Circle, Columbia,sc 29203,united States
Phone
(803)806-3300
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Columbia, SC
Looking for a particular The Ritedose Corporation employee's phone or email?

The Ritedose Corporation Questions

News

From Columbia to the World: Ritedose Redefines Aseptic Manufacturing - Genetic Engineering and Biotechnology News

From Columbia to the World: Ritedose Redefines Aseptic Manufacturing Genetic Engineering and Biotechnology News

Ritedose and Newberry College Forge Strategic Partnership to Launch Pharmaceutical Manufacturing Program - PR Newswire

Ritedose and Newberry College Forge Strategic Partnership to Launch Pharmaceutical Manufacturing Program PR Newswire

CDMO Ritedose increases capacity in move away from compounding to produce more FDA-approved products - Fierce Pharma

CDMO Ritedose increases capacity in move away from compounding to produce more FDA-approved products Fierce Pharma

BDA and William Blair advise Ritedose on its sale to Novo Holdings - BDA Partners

BDA and William Blair advise Ritedose on its sale to Novo Holdings BDA Partners

Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen Position - GlobeNewswire

Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen Position GlobeNewswire

Columbia pharmaceutical firm to help rollout COVID-19 vaccine - WLTX

Columbia pharmaceutical firm to help rollout COVID-19 vaccine WLTX

The Ritedose Corporation Begins production of Drug to Alleviate National Medication Shortage - PR Newswire

The Ritedose Corporation Begins production of Drug to Alleviate National Medication Shortage PR Newswire

Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand for Ophthalmic and Respiratory Medications - PR Newswire

Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand for Ophthalmic and Respiratory Medications PR Newswire

RiteDose Efficiency Innovation Yields Up to 25% Increase in CDMO Production Capability - GlobeNewswire

RiteDose Efficiency Innovation Yields Up to 25% Increase in CDMO Production Capability GlobeNewswire

Recall of Albuterol Used in Nebulizers - WBRC 6 News

Recall of Albuterol Used in Nebulizers WBRC 6 News

Ritedose Adds Seventh Syntegon Packaging Line to Expand Single Vial Packaging Capabilities, Support Production of new COPD Drug Ohtuvayre - PR Newswire

Ritedose Adds Seventh Syntegon Packaging Line to Expand Single Vial Packaging Capabilities, Support Production of new COPD Drug Ohtuvayre PR Newswire

Ritedose Expands Commitment to Service with 1,000 Hours of Purpose Initiative - PR Newswire

Ritedose Expands Commitment to Service with 1,000 Hours of Purpose Initiative PR Newswire

Ritedose Awarded 503B Compounded Medications Agreement with Premier, Inc. - PR Newswire

Ritedose Awarded 503B Compounded Medications Agreement with Premier, Inc. PR Newswire

Ritedose Pharmaceuticals Receives FDA Approval for Albuterol Sulfate Inhalation Solution, 0.5% (2.5 mg/0.5 mL)*--Addressing Nationwide Shortage of the Essential Drug - PR Newswire

Ritedose Pharmaceuticals Receives FDA Approval for Albuterol Sulfate Inhalation Solution, 0.5% (2.5 mg/0.5 mL)*--Addressing Nationwide Shortage of the Essential Drug PR Newswire

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)* - PR Newswire

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)* PR Newswire

Top The Ritedose Corporation Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant